Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: Role of microglia

GLIA

Volumn 38, Issue 1, 2002, Pages 15-23

  Ryu, Jae K ^a   Shin, Won H ^a   Kim, Jean ^a   Joe, Eun H ^a   Lee, Yong B ^a   Cho, Kyung G ^a   Oh, Young J ^a,b   Kim, Seung U ^a   Jin, Byung K ^a  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Endotoxin; Glia; Inducible nitric oxide synthase; Neuronal cell death; Parkinson's disease

Indexed keywords

AVIAN PROTEIN; BSG PROTEIN, GALLUS GALLUS; BSG PROTEIN, RAT; CD147 ANTIGEN; DOPAMINE; ENZYME INHIBITOR; GANGLIOSIDE; GANGLIOSIDE, GT1; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLASMA PROTEIN; TUMOR ANTIGEN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL DEATH; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; GLIOSIS; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROGLIA; NERVE CELL; PARKINSON DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD147; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; AVIAN PROTEINS; BLOOD PROTEINS; CELL DEATH; DOPAMINE; ENZYME INHIBITORS; FEMALE; GANGLIOSIDES; GLIOSIS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MICROGLIA; NEURONS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 0036544646     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10047     Document Type: Article

References (57)

1. Microglial response to 6-hydroxydopamine-induced substantia nigra lesions
2. Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging
3. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson's disease
4. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
5. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures
6. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase
7. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system
8. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
9. GT1b ganglioside induces death of dopaminergic neurons in rat mesencephalic cultures
10. Human ramified microglial ceils produce nitric oxide upon Escherichia coli lipopolysaccharide and tumor necrosis factor alpha stimulation
11. Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia
12. Human monocytes/macrophages: NO or no NO?
13. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease
14. Induction of nitric oxide production by ganglioside GM3 in murine peritoneal macrophages activated for tumor cytotoxicity
15. Ganglioside monoclonal antibody (A2B5) labels Alzheimer's tangles
16. Activated human microglia produce the excitotoxin quinolinic acid
17. Gangliosides prevent glutamate and kinate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex
18. Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation
19. Brain glia release factors with opposing actions upon neuronal survival
20. Gangliosides prevent MPTP toxicity in mice: An Immunocytochemical study
21. Glial cells and Parkinson's disease
22. Biochemical changes in idiopathic Parkinson's disease, aging, and MPTP Parkinsonism: Similarities and differences
23. FcεRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-α in glial cells
24. Dopamine differentiation factors produce partial motor recovery in 6-hydroxydopamine lesioned rats
25. +) neurotoxicity in rats
26. Glutamate neurotoxicity in mesencephalic dopaminergic neurons in culture
27. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia
28. Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system
29. Intraventricular administration of nitric oxide synthase inhibitors prevents delayed neuronal death in gerbil hippocampal CA1 neurons
30. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
31. Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies
32. Topographical atlas of the gangliosides of the adult human brain
33. Cytokine production by human fetal microglia and astrocytes: Differential induction by lipopolysaccharide and IL-1β
34. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
35. Monoclonal antibody to embryonic CNS antigen A2B5 provides evidence for the involvement of membrane components at sites of Alzheimer degeneration and detects sulfatides as well as gangliosides
36. Parkinson's disease
37. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
38. Rate of cell death in parkinsonism indicates active neuropathological process
39. Role of protein kinase C in microglia-induced neurotoxicity in mesencephalic cultures
40. Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures
41. Activation of microglia cells by beta-amyloid protein and interferon-gamma
42. Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures
43. Synthesis of nitric oxide in CNS glial cells
44. Gangliosides activate cultured rat brain microglia
45. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment
46. A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis
47. +-induced damage: Dependence on initial damage and time of treatment
48. Gangliosides of human cerebrospinal fluid in various neurologic diseases
49. Ruthenium red neurotoxicity and interaction with ganglioside in primary cortical cultures
50. Complement and cytokine gene expression in cultured microglial derived from postmortem human brains
51. Cyclooxygenase-2 is highly expressed in microglial-like cells in a murine model of prion disease
52. NG-nitro-L-arginine enhances neuronal death following transient forebrain ischemia in gerbils
53. Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat
54. Neuronal damage following intraspinal injection of a nitric oxide synthase inhibitor in the rat
55. Gangliosides enhance apoptosis of thymocytes
56. The effect of microglia on embryonic dopaminergic neuronal survival in vitro: Diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective